Ensemble Orthopedics Reaches Milestone with Ensemble CMC Joint Replacement

By Julie A. Vetalice

Ensemble Orthopedics Reaches Milestone with Ensemble CMC Joint Replacement

Ensemble Orthopedics announced the 100th implantation of the Ensemble CMC™ minimally invasive joint replacement for the treatment of carpometacarpal (CMC or thumb) osteoarthritis, coinciding with the one-year anniversary of market introduction.

The FDA-cleared Ensemble CMC was designed to expand treatment options for CMC osteoarthritis in a wider range of patients by replacing only the affected bearing surfaces of the carpal and metacarpal bones. The interpositional device is inserted through a small incision with minimal disruption to the joint capsule or stabilizing soft tissue structures of the thumb. Ensemble CMC is manufactured from pyrocarbon, a low friction material with a proven history of durability and biocompatibility in orthopedic implants.

"The CMC implant is our initial offering in a complete line of minimally invasive implants for the hand and wrist," said William Ogilvie, Co-founder and CEO of Ensemble Orthopedics. "Our early experience suggests the implant presents an attractive choice for surgeons to offer patients and is becoming an accepted treatment alternative."

Source: Ensemble Orthopedics, Inc.

Product Labels: Finger/Hand/Wrist Replacement